Table: Takara Bio -Q1 group results
Aug 4 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2020 Jun 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6.94 8.65 39.60
(-19.8 pct) (-2.2 pct) (+14.6 pct)
Operating 693 mln 2.25 6.50
(-69.2 pct) (+45.8 pct) (+3.6 pct)
Recurring 745 mln 2.20 6.60
(-66.1 pct) (+41.1 pct) (+4.0 pct)
Net 404 mln 1.59 4.00
(-74.6 pct) (+54.2 pct) (+4.7 pct)
EPS 3.36 yen 13.22 yen 33.22 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T